ROIV
Roivant Sciences
·
$34.51
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Terminal终端 ↗
Roivant Sciences · Health Care
ROIV
$34.51
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.RoivantSciencesLtd.是一家美国跨国医疗保健公司，专注于将技术应用于药物开发，并构建子公司生命科学和健康科技公司。
Speculative / unprofitable投机／未盈利
Large cap大盘
$24B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$34.51
6.2% below 52-week high低于52周高点 6.2%
Market Cap市值
$24B
Normal volume正常成交量
Beta贝塔
1.04
Moves about 1.0x the market波动幅度约为市场的 1.0 倍
RSI (14)RSI（14）
56
Neutral zone中性区域
Next Earnings下次财报
2026-08-10 (22d)
Volatility Rank波动率分位
60th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
4.7% of float
Performance价格表现
| Period周期 | ROIV | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -4.1% | -1.5% | Lagged the index by 2.6 points落后指数 2.6 个百分点 |
| 1 Month近1月 | +10.6% | +0.6% | Beat the index by 10.0 points跑赢指数 10.0 个百分点 |
| 3 Months近3月 | +15.7% | +4.7% | Beat the index by 11.0 points跑赢指数 11.0 个百分点 |
| 6 Months近6月 | +49.2% | +7.8% | Beat the index by 41.4 points跑赢指数 41.4 个百分点 |
| Year to date年初至今 | +57.4% | +9.1% | Beat the index by 48.3 points跑赢指数 48.3 个百分点 |
| 1 Year近1年 | +196.2% | +19.4% | Beat the index by 176.8 points跑赢指数 176.8 个百分点 |
| 3 Years近3年 | +192.2% | +69.4% | Beat the index by 122.8 points跑赢指数 122.8 个百分点 |
Technicals技术面
RSI (14)RSI（14）
56
Neutral zone中性区域
vs 50-day相对50日均线
+9.7% vs 50-day avg
vs 200-day相对200日均线
+35.3% vs 200-day avg
Volatility rank波动率分位
60th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$33.66
Don't chase above不追高于
$34.51
Stop止损
$29.73
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
22
days until next report天后公布财报
2026-08-10
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | ROIV | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 5.74x | 3.52 | 26% |
| P/S市销率 | 2965.06x | 3.02 | 0% |
| Earnings yield盈利收益率 | -1.22% | 2.72 | 21% |
| FCF yield自由现金流收益率 | -3.45% | 3.94 | 7% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: -27.5%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
-7.0%Return on Equity股本回报率
-5.7%Return on Assets资产回报率
Leverage杠杆
| Current ratio流动比率 | 33.47 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $289.0M |
| Share count change (1y)股数变化（1年） | -1.4% |
Piotroski皮奥特罗斯基 2/7
Altman Z阿尔特曼Z: safe (59.3)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 11% of its sector on blended multiples综合估值倍数低于行业内 11% 的公司
Beta市场敏感度
1.04×
0.21×3×
Moves about 1.0× the market波动幅度约为市场的 1.0 倍
Financial Health财务健康
2/7
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
ROIV daily MACD crossed downROIV 日线MACD下穿
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$627.5M net (0 buyers, 11 sellers)-$627.5M 净值（0 买家，11 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | Holding持有 | 4.5% | 2026-03-31 |
| Viking Global (Halvorsen) | B | Holding持有 | 0.5% | 2026-03-31 |
| Baker Bros. Advisors | A | trimtrim | 0.8% | 2026-03-31 |
| Polen Capital Management | B | exitexit | 0.0% | 2026-03-31 |
| Soros Fund Management | B | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 14, 2026
ROIV daily MACD crossed downROIV 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $34.91.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$34.91。
Jul 9, 2026
ROIV made a new 52-week highROIV 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $36.81.价格创出52周新高 — 全市场关注的动量/趋势极值。$36.81。
Jul 6, 2026
ROIV made a new 52-week highROIV 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $35.39.价格创出52周新高 — 全市场关注的动量/趋势极值。$35.39。
Jun 26, 2026
ROIV weekly MACD crossed upROIV 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Jun 24, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jun 24, 2026
ROIV made a new 52-week highROIV 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $34.01.价格创出52周新高 — 全市场关注的动量/趋势极值。$34.01。
Jun 24, 2026
ROIV RSI reached overboughtROIV RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $34.01.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$34.01。
Jun 23, 2026
ROIV took relative-strength leadershipROIV 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $32.21.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$32.21。
Jun 18, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Showing last 15 of显示最近15条，共 252 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.58
Value价值
-1.1
Quality质量
-2.1
Investment资本投入
+1.1
Low volatility低波动
-0.2
Low market beta低市场敏感度
-0.3
Earnings quality盈利质量
-2.2
Short interest空头兴趣
+0.0
Company Profile公司档案
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.RoivantSciencesLtd.是一家美国跨国医疗保健公司，专注于将技术应用于药物开发，并构建子公司生命科学和健康科技公司。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Capital intensity rising
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。